OS Therapies grants CFO Knuettel 250,000 restricted stock units, 750,000 stock options
OSTX•OS Therapies granted CFO Francis Knuettel II 250,000 shares of common stock on Nov. 10, 2026, and options to buy 750,000 shares at $0.89 each, expiring Nov. 10, 2036.
1. CFO stock awards
OS Therapies granted Chief Financial Officer Francis Knuettel II 250,000 shares of common stock on Nov. 10, 2026. He also received options to purchase 750,000 common shares at an exercise price of $0.89, expiring Nov. 10, 2036.
